BioNTech acquires Biotheus for $800 million plus milestone payments, securing global rights to BNT327/PM8002 and expanding ...

A new vaccine, designed to protect East African cattle against all major strains of foot and mouth disease, is offering hope to small-scale farmers battling the highly contagious disease. Foot and ...

U.S. FDA removes clinical hold on Investigational New Drug application for COVID-19-Influenza Combination and stand-alone influenza vaccine candidates Achieved total ...

German drugmaker BioNTech on Monday lowered its guidance for full-year revenue, citing COVID-19 uptake and price levels, inventory write-downs and Pfizer charges.

Malaria is as old as the Egyptian civilization, and the fight against it spans nearly 100 years in Egypt. Egypt recently achieved a monumental feat by receiving WHO certification for eliminating ...

The study, published Oct. 11 in Science Immunology, removes one more barrier to developing a vaccine for HIV, and potentially other diseases such as malaria and cancer. Daniel Malouli, Ph.D ...

N’Djamena — Chad today kicked off an ambitious triple vaccine rollout, including the R21 malaria vaccine, marking a significant step forward in its efforts to safeguard the health and well ...

No progresses in malaria vaccine development will ever be considered rapid enough when confronted by the global threat that malaria disease poses to human lives and development. Nevertheless ...

On Aug. 22, the Food and Drug Administration approved and authorized newer formulations of the two mRNA vaccines, from Pfizer/BioNTech and Moderna, for ages 6 months and up. About a week later ...

Advancements in vaccine development for parasitic infections, particularly malaria, are crucial for reducing global health burdens in vulnerable populations.

EMVI = European malaria vaccine initiative; GLURP = Glutamate-rich protein; GSK = GlaxoSmithKline; LSA = Liver-stage antigen; LSP = Long-synthetic peptide; ME-TRAP = Multiepitope-thrombospondin ...